Uses of NOGO-A inhibitors and related methods
US8828390B2 · kind B2 · utility
48Cited by
0References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 8, 2011 |
| Grant date | Sep 9, 2014 |
| Priority date | — |
| Expiry date | Jul 8, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to Nogo-A antagonists useful for the control of blood glucose or blood insulin levels in a subject and related use and formulation thereof. In particular, the invention is directed to Nogo-A antagonists useful for the prevention, repression or treatment insulin secretion deficiency and related methods and pharmaceutical formulations. In particular, the invention relates to Nogo-A antagonists useful in the treatment of diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.